• Explore /
  • Poster
  • / Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: Propensity score–matched recurrence-free, distant metastasis-free, and overall survival analysis.

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: Propensity score–matched recurrence-free, distant metastasis-free, and overall survival analysis.

Abstract Poster

Authors

null

Manja Bloem

Leiden University Medical Center, Leiden, Netherlands

Manja Bloem , Melissa Melanie de Meza , Maureen J.B. Aarts , Franchette Van Den Berkmortel , Christian U. Blank , Willeke Blokx , Marye J. Boers-Sonderen , Han J. Bonenkamp , Jan Willem de Groot , John Haanen , Geke Hospers , Ellen Kapiteijn , Djura Piersma , Rozemarijn van Rijn , Marion Stevense - den Boer , Astrid Aplonia Maria Van Der Veldt , Gerard Vreugdenhil , Alfonsus Johannes Maria van den Eertwegh , Karijn Suijkerbuijk , Michel WJM Wouters

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 9573)

DOI

10.1200/JCO.2024.42.16_suppl.9573

Abstract #

9573

Poster Bd #

357

Abstract Disclosures

Similar Posters

First Author: Kartik Sehgal

Poster

2020 ASCO Virtual Scientific Program

Melanoma recurrence after adjuvant targeted therapy: A multicenter analysis.

Melanoma recurrence after adjuvant targeted therapy: A multicenter analysis.

First Author: Prachi Bhave

First Author: Vincent T. Ma

First Author: Zahra Hamedi